Search

everythinglearnresearchcommunity

for

Search:↓

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Metformin is less effective in men with early-onset hair loss.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

The woman's high testosterone levels indicated PCOS, leading to treatment that improved her symptoms.

A woman's male-like physical changes were caused by two rare ovarian conditions.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.